Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dezhou Bocheng Pharmaceutical is a Chinese pharmaceutical manufacturing company and a key subsidiary of Shandong Buchang Pharmaceuticals. The company focuses on the production of active pharmaceutical ingredients (APIs) and finished chemical drug products, particularly in the cardiovascular and cerebrovascular therapeutic areas. Operating out of Dezhou, Shandong, the firm maintains modern GMP-certified facilities that support large-scale chemical synthesis and formulation. Dezhou Bocheng serves as a critical production base for its parent group, contributing to a broad portfolio of essential medicines distributed throughout China. The company is recognized as a high-tech enterprise, integrating research, development, and industrial-scale manufacturing to support both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 德州博诚制药.